Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer
PaperCitations, authors & open-access status
T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 29 citations, 2017 year and bronze oa status.
29
Citations
2017
Year
bronze
OA Status